Max Small Mauro
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Max Small Mauro has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Jorge Raúl Mendoza Fabian
Hospital Edgardo Rebagliati Martins, Lima, Perú; Sociedad de Neumología peruana (SNP); Asociación latinoamericana de Tórax (ALAT); European Respiratory Society (ERS); Universidad Nacional Mayor de San Marcos, Lima, Perú; Sociedad Española de Neumología y Cirugía Torácica (SEPAR)
2 shared publications - Abel Rivadeneyra-Rodríguez
Servicio de Odontoestomatologia del Hospital Edgardo Rebagliati Martins, EsSalud, Lima, Perú
1 shared publication - Alexis Lizarzaburu
Servicio de Neumología del Hospital Edgardo Rebagliati Martins , EsSalud, Lima, Perú
1 shared publication - José Somocurcio-Peralta
School of Medicine, Universidad Nacional Mayor de San Marcos, Lima, Peru
1 shared publication - Mayra Aurelia Valderrama Saldaña
Hospital Nacional Edgardo Rebagliati Martins
1 shared publication - Stalin Vilcarromero
Servicio de Infectologia, Hospital Nacional Edgardo Rebagliati Martins, ESSALUD, Lima, Perú
1 shared publication
Latest Publications
- Open Access
- 19 January 2026
- Published by Asociacion Colombiana de Neumologia y Cirugia de Torax in Revista Colombiana de Neumología
- Vol. 38 (1)
Sarcoma sinovial pleuropulmonar: reporte de una entidad inusual en un hospital peruano
Primary pulmonary synovial sarcoma (SS) is a tumor derived from pluripotential mesenchymal cells. It accounts for 0.1-0.5% of all pulmonary tumors and typically occurs in young, non-smoking individuals, classified according to the cellular pattern as monophasic or biphasic. Intrathoracic involvement can occur in various locations, including the pleuropulmonary region, mediastinum, thoracic wall, trachea, and diaphragm. Diagnosis is challenging and treatment includes surgery, chemotherapy, and radiotherapy. We present the case of a 65-year-old male patient with no smoking history who was admitted due to progressive dyspnea, chest pain, and weight loss. Thoracic computed tomography revealed moderate pleural effusion associated with a heterogeneous mass in the left hemithorax. Histopathology of the tissue obtained by percutaneous biopsy reported a primarily monophasic synovial sarcoma. Palliative treatment with serial pleural drainage, chemical pleurodesis, and pain management was indicated. The patient passed away 10 months after the onset of symptoms.
- 19 January 2026
- Published by Asociacion Colombiana de Neumologia y Cirugia de Torax in Revista Colombiana de Neumología
- Vol. 38 (1)
Open AccessSarcoma sinovial pleuropulmonar: reporte de una entidad inusual en un hospital peruano
Primary pulmonary synovial sarcoma (SS) is a tumor derived from pluripotential mesenchymal cells. It accounts for 0.1-0.5% of all pulmonary tumors and typically occurs in young, non-smoking individuals, classified according to the cellular pattern as monophasic or biphasic. Intrathoracic involvement can occur in various locations, including the pleuropulmonary region, mediastinum, thoracic wall, trachea, and diaphragm. Diagnosis is challenging and treatment includes surgery, chemotherapy, and radiotherapy. We present the case of a 65-year-old male patient with no smoking history who was admitted due to progressive dyspnea, chest pain, and weight loss. Thoracic computed tomography revealed moderate pleural effusion associated with a heterogeneous mass in the left hemithorax. Histopathology of the tissue obtained by percutaneous biopsy reported a primarily monophasic synovial sarcoma. Palliative treatment with serial pleural drainage, chemical pleurodesis, and pain management was indicated. The patient passed away 10 months after the onset of symptoms.
- Open Access
- 1 December 2025
- Published by Asociacion Latinoamericana de Torax in Respirar
- Vol. 17 (4) , 544-549
Diagnóstico de mesotelioma pleural mediante criobiopsia pleuroscópica: reporte de un caso
Introduction: Pleural mesothelioma (PM) is a rare and aggressive malignant neoplasm that originates from the mesothelial surface of the pleura. Cryobiopsy (CB) has been described as a safe and highly effective diagnostic technique for pleural pathology, due to the larger sample size and fewer artifacts. Case report: A 76-year-old female patient presented with progressive dyspnea and chest pain. Chest imaging revealed a left pleural effusion which was consistent with a lymphocytic exudate with normal adenosine deaminase levels and negative microbiology. Pleuroscopy showed parietal pleura with nodular infiltrates. Samples were obtained using a 1.7 mm diameter cryoprobe. Cryobiopsies revealed epithelioid pleural mesothelioma. Immunohistochemical analysis was positive for calretinin and negative for thyroid transcription factor 1 (TTF1), cytokeratin 7 (CK7), and cytokeratin 20 (CK20). Discussion: The use of pleural cryobiopsy via pleuroscopy as a diagnostic method has demonstrated superiority compared to the use of forceps. Furthermore, there is limited evidence regarding its use for the diagnosis of pleural mesothelioma. We describe the following successfully performed clinical case, demonstrating the usefulness of pleural cryobiopsy during pleuroscopy in the diagnosis of pleural mesothelioma. Conclusions: We present a clinical case that illustrates the usefulness of pleural cryobiopsy through pleuroscopy for the diagnosis of pleural mesothelioma, in which large and extensive samples are required to define the anatomopathological diagnosis.
- 1 December 2025
- Published by Asociacion Latinoamericana de Torax in Respirar
- Vol. 17 (4) , 544-549
Open AccessDiagnóstico de mesotelioma pleural mediante criobiopsia pleuroscópica: reporte de un caso
Introduction: Pleural mesothelioma (PM) is a rare and aggressive malignant neoplasm that originates from the mesothelial surface of the pleura. Cryobiopsy (CB) has been described as a safe and highly effective diagnostic technique for pleural pathology, due to the larger sample size and fewer artifacts. Case report: A 76-year-old female patient presented with progressive dyspnea and chest pain. Chest imaging revealed a left pleural effusion which was consistent with a lymphocytic exudate with normal adenosine deaminase levels and negative microbiology. Pleuroscopy showed parietal pleura with nodular infiltrates. Samples were obtained using a 1.7 mm diameter cryoprobe. Cryobiopsies revealed epithelioid pleural mesothelioma. Immunohistochemical analysis was positive for calretinin and negative for thyroid transcription factor 1 (TTF1), cytokeratin 7 (CK7), and cytokeratin 20 (CK20). Discussion: The use of pleural cryobiopsy via pleuroscopy as a diagnostic method has demonstrated superiority compared to the use of forceps. Furthermore, there is limited evidence regarding its use for the diagnosis of pleural mesothelioma. We describe the following successfully performed clinical case, demonstrating the usefulness of pleural cryobiopsy during pleuroscopy in the diagnosis of pleural mesothelioma. Conclusions: We present a clinical case that illustrates the usefulness of pleural cryobiopsy through pleuroscopy for the diagnosis of pleural mesothelioma, in which large and extensive samples are required to define the anatomopathological diagnosis.
- Open Access
- 30 August 2024
- Published by Universidad Nacional Mayor de San Marcos, Vicerectorado de Investigacion in Anales de la Facultad de Medicina
- Vol. 85 (3) , 324-328
Primera experiencia de criobiopsia transbronquial para enfermedad pulmonar intersticial difusa en un hospital nacional de Lima, Perú
Transbronchial cryobiopsy has been described as a new method to obtain lung tissue, demonstrating good correlation with surgical lung biopsies, fewer complications, costs and hospital stay. We describe our first experience carried out successfully in a national hospital. This is a 53-year-old female patient, with a disease duration of five years, characterized by progressive dyspnea. Non-UIP standard tomography. Rheumatological study: mixed positive ANA, speckled nuclear 1/2560 and nucleolar 1/5120. Anti-ENA positive, ANCA negative. Spirometry with FVC 1.83 (69%) and diffusion test 10.39 (67%). After the evaluation of the multidisciplinary committee, a lung biopsy was indicated. After clinical and functional evaluation, cryobiopsy was performed with the use of general anesthesia, prophylactic endobronchial blocker, fluoroscopic guidance and cryoprobe.
- 30 August 2024
- Published by Universidad Nacional Mayor de San Marcos, Vicerectorado de Investigacion in Anales de la Facultad de Medicina
- Vol. 85 (3) , 324-328
Open AccessPrimera experiencia de criobiopsia transbronquial para enfermedad pulmonar intersticial difusa en un hospital nacional de Lima, Perú
Transbronchial cryobiopsy has been described as a new method to obtain lung tissue, demonstrating good correlation with surgical lung biopsies, fewer complications, costs and hospital stay. We describe our first experience carried out successfully in a national hospital. This is a 53-year-old female patient, with a disease duration of five years, characterized by progressive dyspnea. Non-UIP standard tomography. Rheumatological study: mixed positive ANA, speckled nuclear 1/2560 and nucleolar 1/5120. Anti-ENA positive, ANCA negative. Spirometry with FVC 1.83 (69%) and diffusion test 10.39 (67%). After the evaluation of the multidisciplinary committee, a lung biopsy was indicated. After clinical and functional evaluation, cryobiopsy was performed with the use of general anesthesia, prophylactic endobronchial blocker, fluoroscopic guidance and cryoprobe.
- Open Access
- 20 March 2023
- Published by Instituto Nacional de Salud (Peru) in Revista Peruana de Medicina Experimental Y Salud Pública
- Vol. 40 (1) , 99-104
Empiema pleural por Parvimonas micra en un paciente inmunocompetente: reporte de un caso
Se presenta el caso de un paciente joven inmunocompetente, con antecedente de tuberculosis pulmonar, que acude al hospital por un cuadro clínico subagudo de fiebre persistente, baja de peso, disnea y abolición del murmullo vesicular. La tomografía de tórax mostró un extenso empiema en hemitórax izquierdo. Se le toman muestras para detección de gérmenes comunes y se le colocan un tubo de drenaje torácico y se inicia antibioticoterapia. La prueba de MALDI-TOF MS identificó a Parvimonas micra, una bacteria anaerobia, comensal de la flora oral, asociado a periodontitis severa, escasamente reportado en empiema pleural, especialmente, en personas inmunocompetentes. En la evaluación odontológica se realizó el diagnóstico de gingivitis y pericoronaritis de la tercera molar. El paciente evolucionó favorablemente. Se sugiere que, en casos de empiemas pleurales subagudos o crónicos, se debe considerar, además de las micobacterias, como agente etiológico al Parvimonas micra, y optar por exámenes como MALDI-TOF MS o secuenciamiento del 16S rRNA, colocación de tubo de tórax, cobertura antibiótica empírica y evaluación odontológica.
- 20 March 2023
- Published by Instituto Nacional de Salud (Peru) in Revista Peruana de Medicina Experimental Y Salud Pública
- Vol. 40 (1) , 99-104
Open AccessEmpiema pleural por Parvimonas micra en un paciente inmunocompetente: reporte de un caso
Se presenta el caso de un paciente joven inmunocompetente, con antecedente de tuberculosis pulmonar, que acude al hospital por un cuadro clínico subagudo de fiebre persistente, baja de peso, disnea y abolición del murmullo vesicular. La tomografía de tórax mostró un extenso empiema en hemitórax izquierdo. Se le toman muestras para detección de gérmenes comunes y se le colocan un tubo de drenaje torácico y se inicia antibioticoterapia. La prueba de MALDI-TOF MS identificó a Parvimonas micra, una bacteria anaerobia, comensal de la flora oral, asociado a periodontitis severa, escasamente reportado en empiema pleural, especialmente, en personas inmunocompetentes. En la evaluación odontológica se realizó el diagnóstico de gingivitis y pericoronaritis de la tercera molar. El paciente evolucionó favorablemente. Se sugiere que, en casos de empiemas pleurales subagudos o crónicos, se debe considerar, además de las micobacterias, como agente etiológico al Parvimonas micra, y optar por exámenes como MALDI-TOF MS o secuenciamiento del 16S rRNA, colocación de tubo de tórax, cobertura antibiótica empírica y evaluación odontológica.